EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities

Shivam Chowdhary, Rahul Deka, Kingshuk Panda, Rohit Kumar, Abhishikt David Solomon, Jimli Das, Supriya Kanoujiya, Ashish Kumar Gupta, Somya Sinha, Janne Ruokolainen, Kavindra Kumar Kesari iD, Piyush Kumar Gupta iD

Molecular Pharmaceutics · 2023

DOI: 10.1021/acs.molpharmaceut.2c01080 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Shivam Chowdhary und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Industrial Microbiology, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, Uttar Pradesh India. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 409 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human viral oncogenesis is a complex phenomenon and a major contributor to the global cancer burden. Several recent findings revealed cellular and molecular pathways that promote the development and initiation of malignancy when viruses cause an infection. Even, antiviral treatment has become an approach to eliminate the viral infections and prevent the activation of oncogenesis. Therefore, for a better understanding, the molecular pathogenesis of various oncogenic viruses like, hepatitis virus, human immunodeficiency viral (HIV), human papillomavirus (HPV), herpes simplex virus (HSV), and Epstein-Barr virus (EBV), could be explored, especially, to expand many potent antivirals that may escalate the apoptosis of infected malignant cells while sparing normal and healthy ones. Moreover, contemporary therapies, such as engineered antibodies antiviral agents targeting signaling pathways and cell biomarkers, could inhibit viral oncogenesis. This review elaborates the recent advancements in both natural and synthetic antivirals to control viral oncogenesis. The study also highlights the challenges and future perspectives of using antivirals in viral oncogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsNeoplasmsHumansHerpesvirus 4, HumanCarcinogenesisAntiviral Agents

Stichwörter der Autor:innen

Antiviral AgentsMalignancyOncovirusesTherapeuticsViral Oncogenesis

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Industrial Microbiology, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, Uttar Pradesh India.
  • Department of Bioengineering and Biotechnology, Birla Institute of Technology, Mesra, Ranchi 835215, Jharkhand, India.
  • Department of Applied Microbiology, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India.
  • Department of Life Sciences, Sharda School of Basic Sciences and Research, Sharda University, Greater Noida 201310, Uttar Pradesh, India.
  • Department of Molecular & Cellular Engineering, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, Uttar Pradesh, India.
  • Centre for Biotechnology and Bioinformatics, Dibrugarh University, Assam 786004, India.

ORCID-Profile: Kavindra Kumar Kesari, Piyush Kumar Gupta

Zitieren

APA

Chowdhary, S., Deka, R., Panda, K., Kumar, R., Solomon, A. D., Das, J., Kanoujiya, S., Gupta, A. K., Sinha, S., Ruokolainen, J., Kesari, K. K., & Gupta, P. K. (2023). Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.2c01080

Vancouver

Chowdhary S, Deka R, Panda K, Kumar R, Solomon AD, Das J, et al. Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.2c01080

BibTeX
@article{Chowdhary2023,
  author = {Chowdhary, Shivam and Deka, Rahul and Panda, Kingshuk and Kumar, Rohit and Solomon, Abhishikt David and Das, Jimli and Kanoujiya, Supriya and Gupta, Ashish Kumar and Sinha, Somya and Ruokolainen, Janne and Kesari, Kavindra Kumar and Gupta, Piyush Kumar},
  title = {Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  doi = {10.1021/acs.molpharmaceut.2c01080}
}
Kostenlos starten →